Antihelminthic drug for T2DM therapy?

被引:1
|
作者
Joana Osório
机构
关键词
D O I
10.1038/nrendo.2014.183
中图分类号
学科分类号
摘要
引用
收藏
页码:702 / 702
相关论文
共 50 条
  • [1] Designing a new therapy for T2DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (12) : 684 - 684
  • [2] Designing a new therapy for T2DM
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 684 - 684
  • [3] Effect of Psycho-drug Therapy in Elderly Depressive Patients with T2DM
    Zhang, Ji
    Li, Li
    Tu, Xiaodong
    Yu, Ping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [4] Treating T2DM with Early Insulin Therapy
    Agarwal, Amit
    Norton, Pamela
    McNamara, John
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (09): : 49 - +
  • [5] Surgical or medical therapy for patients with obesity and T2DM?
    Sten Madsbad
    Jens J. Holst
    Nature Reviews Endocrinology, 2016, 12 : 500 - 502
  • [6] Perioperative Liraglutide Therapy for Japanese Subjects With T2DM
    Katagiri, Naoko
    Kaneko, Shizuka
    Tahara, Yumiko
    Sato, Yuichi
    Hamano, Kumiko
    DIABETES, 2013, 62 : A268 - A268
  • [7] Surgical or medical therapy for patients with obesity and T2DM?
    Madsbad, Sten
    Holst, Jens J.
    NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (09) : 500 - 502
  • [8] THERAPY Achieving T2DM remission in primary care
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (02) : 66 - 66
  • [9] THERAPY Liraglutide - preventing or postponing T2DM diagnosis?
    Vilsboll, Tina
    Knop, Filip K.
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (06) : 320 - 321
  • [10] In obesity with T2DM, biliopancreatic diversion increased T2DM remission vs. medical and lifestyle therapy at 10 y
    Sarma, Shohinee
    Lipscombe, Lorraine L.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : JC70 - JC70